BackAgilon Health Overview

Agilon Health Profit Margin

Valuation check: AGL's profit margin is -6.42%, below the Healthcare sector average of 15.29%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

2.11%
167.02% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-6.42%
58.82% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Agilon Health (AGL) FAQ

Agilon Health (AGL) currently reports a profit margin of -6.42% as of March 2026. That compares with -4.04% in the prior-year period — down 58.8% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Agilon Health's profit margin history and peer comparisons.

Agilon Health's profit margin decreased from -4.04% to -6.42% — a 58.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Agilon Health's profit margin of -6.42% is lower than the Healthcare sector average of 15.29%. That is roughly 142.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Agilon Health's current -6.42% should be judged against Healthcare norms (sector average: 15.29%) and against AGL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -6.42%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Agilon Health, and consider following AGL for alerts when major investors trade the stock.